Alcon’s decision to voluntarily recall its CyPass micro-stent from the global market was the most-read article on Healio.com/OSN in August.
Here are the month’s top five stories:
Alcon calls for surgeons to stop implanting CyPass micro-stent
According to a company press release, the decision was based on safety data from the COMPASS-XT study, which found a statistically significant difference in endothelial cell loss at 5 years after surgery in patients who received the device in conjunction with cataract surgery compared to those who underwent cataract surgery alone. Read
Uncategorized